tetano
Editor, Senior Moderator
Antiviral Res
. 2023 Mar 26;105587.
doi: 10.1016/j.antiviral.2023.105587. Online ahead of print.
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants
Emiel Vanhulle[SUP] 1 [/SUP], Jordi Doijen[SUP] 1 [/SUP], Joren Stroobants[SUP] 1 [/SUP], Becky Provinciael[SUP] 1 [/SUP], Sam Noppen[SUP] 1 [/SUP], Dominique Schols[SUP] 1 [/SUP], Annelies Stevaert[SUP] 1 [/SUP], Kurt Vermeire[SUP] 2 [/SUP]
Affiliations
Abstract
Despite the vaccination campaigns for COVID-19, we still cannot control the spread of SARS-CoV-2, as evidenced by the ongoing circulation of the Omicron variants of concern. This highlights the need for broad-spectrum antivirals to further combat COVID-19 and to be prepared for a new pandemic with a (re-)emerging coronavirus. An interesting target for antiviral drug development is the fusion of the viral envelope with host cell membranes, a crucial early step in the replication cycle of coronaviruses. In this study, we explored the use of cellular electrical impedance (CEI) to quantitatively monitor morphological changes in real time, resulting from cell-cell fusion elicited by SARS-CoV-2 spike. The impedance signal in CEI-quantified cell-cell fusion correlated with the expression level of SARS-CoV-2 spike in transfected HEK293T cells. For antiviral assessment, we validated the CEI assay with the fusion inhibitor EK1 and measured a concentration-dependent inhibition of SARS-CoV-2 spike mediated cell-cell fusion (IC[SUB]50[/SUB] value of 0.13 μM). In addition, CEI was used to confirm the fusion inhibitory activity of the carbohydrate-binding plant lectin UDA against SARS-CoV-2 (IC[SUB]50[/SUB] value of 0.55 μM), which complements prior in-house profiling activities. Finally, we explored the utility of CEI in quantifying the fusogenic potential of mutant spike proteins and in comparing the fusion efficiency of SARS-CoV-2 variants of concern. In summary, we demonstrate that CEI is a powerful and sensitive technology that can be applied to studying the fusion process of SARS-CoV-2 and to screening and characterizing fusion inhibitors in a label-free and non-invasive manner.
Keywords: Cell-cell fusion; Cellular electrical impedance; Entry inhibitor; SARS-CoV-2; Spike.
. 2023 Mar 26;105587.
doi: 10.1016/j.antiviral.2023.105587. Online ahead of print.
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants
Emiel Vanhulle[SUP] 1 [/SUP], Jordi Doijen[SUP] 1 [/SUP], Joren Stroobants[SUP] 1 [/SUP], Becky Provinciael[SUP] 1 [/SUP], Sam Noppen[SUP] 1 [/SUP], Dominique Schols[SUP] 1 [/SUP], Annelies Stevaert[SUP] 1 [/SUP], Kurt Vermeire[SUP] 2 [/SUP]
Affiliations
- PMID: 36977434
- DOI: 10.1016/j.antiviral.2023.105587
Abstract
Despite the vaccination campaigns for COVID-19, we still cannot control the spread of SARS-CoV-2, as evidenced by the ongoing circulation of the Omicron variants of concern. This highlights the need for broad-spectrum antivirals to further combat COVID-19 and to be prepared for a new pandemic with a (re-)emerging coronavirus. An interesting target for antiviral drug development is the fusion of the viral envelope with host cell membranes, a crucial early step in the replication cycle of coronaviruses. In this study, we explored the use of cellular electrical impedance (CEI) to quantitatively monitor morphological changes in real time, resulting from cell-cell fusion elicited by SARS-CoV-2 spike. The impedance signal in CEI-quantified cell-cell fusion correlated with the expression level of SARS-CoV-2 spike in transfected HEK293T cells. For antiviral assessment, we validated the CEI assay with the fusion inhibitor EK1 and measured a concentration-dependent inhibition of SARS-CoV-2 spike mediated cell-cell fusion (IC[SUB]50[/SUB] value of 0.13 μM). In addition, CEI was used to confirm the fusion inhibitory activity of the carbohydrate-binding plant lectin UDA against SARS-CoV-2 (IC[SUB]50[/SUB] value of 0.55 μM), which complements prior in-house profiling activities. Finally, we explored the utility of CEI in quantifying the fusogenic potential of mutant spike proteins and in comparing the fusion efficiency of SARS-CoV-2 variants of concern. In summary, we demonstrate that CEI is a powerful and sensitive technology that can be applied to studying the fusion process of SARS-CoV-2 and to screening and characterizing fusion inhibitors in a label-free and non-invasive manner.
Keywords: Cell-cell fusion; Cellular electrical impedance; Entry inhibitor; SARS-CoV-2; Spike.